Objective:

To showcase the Virtuoso dual-function surgical platform for cataract and vitreoretinal procedures.

Key Findings:

• Virtuoso is designed for both cataract and vitreoretinal procedures.
• The device has not yet received regulatory clearance.
• Currently undergoing premarket clinical investigation at LMU Klinikum in Munich, Germany.

Interpretation:

The introduction of Virtuoso at the Euretina Congress highlights its potential benefits for surgical efficiency, although it remains unapproved for clinical use.

Limitations:

• Lack of regulatory clearance (CE mark and FDA 510(k)).
• Data is still under investigation and not yet validated in clinical practice.

Conclusion:

Virtuoso represents a promising advancement in surgical technology, pending regulatory approval and clinical validation.